Suitable for use in ELISA and Lateral Flow assays. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. Recommended antibody-antigen pair for ELISA and Lateral Flow assays: Antibody Antigen DCABY-625 DAGF-194
Format
Liquid
Concentration
Batch dependent - please inquire should you have specific requirements.
Buffer
PBS, pH 7.4
Preservative
0.02% Sodium Azide
Storage
Short-term store at 2-8°C. Long term store at –20°C. Avoid multiple freeze/thaw cycles.
Have you cited DAGF-194 in a publication? Let us know and earn a reward for your research.
Background
Methamphetamine (METH), also known as desoxyephedrine, is a highly addictive psychostimulant with very strong neurotoxicity to the central nervous system. METH abuse can cause a variety of disorders, including anxiety, psychosis, and paranoia. The mechanism of neurotoxicity is complex and is associated with dopaminergic neuronal dysfunction and loss. METH neurotoxicity can lead to damage to dopamine (DA) neuronal terminals in the brain of abusers and a sustained decline in striatal dopamine levels, triggering metabolic abnormalities and cognitive deficits. In METH-induced CNS inflammation, microglia and astrocytes are activated in several brain regions. Reactive glial cells secrete a variety of inflammatory factors that affect neuronal function. Various influencing factors both play an independent role and cross-promote each other, constituting a vicious circle of brain tissue damage.
During the process of METH causing neurotoxicity in dopaminergic neurons, it leads to excessive release of DA into the cytoplasm through the dopamine transporter. Rapid auto-oxidation of large amounts of DA and its formation of oxidative toxicants leads to oxidative stress, which mediates apoptosis and neuronal damage in dopaminergic neurons. On the other hand, it induces alterations in the mitochondrial respiratory chain within dopaminergic neurons and disrupts the outer mitochondrial membrane via the mitochondrial apoptotic pathway, affecting the balance of anti-apoptotic to pro-apoptotic protein ratios. METH also directly induces neuroinflammation, in which NFκB and inflammatory factors play an important role. It has been shown that METH-induced neuroinflammation in SH-SY5Y cells involves NFκB activation.
Figure 1. Possible mechanisms of methamphetamine-induced neurotoxicity (Source: Jayanthi S, et al. 2021)
The end result of neurotoxicity is that cell death occurs. Numerous studies have shown that cytotoxicity due to METH exposure is closely related to programmed cell death in the form of apoptosis, necroptosis, autophagy, pyroptosis, and ferroptosis. Apoptosis induced by METH occurs and is regulated in relation to multiple signaling pathways, mainly the exogenous death receptor pathway, the endogenous mitochondrial pathway and the endoplasmic reticulum stress pathway. METH exposure not only harms the nervous system, but also causes serious damage to other systems. Some researchers have found a significant increase in apoptosis and a significant increase in lysis of Caspase-3 and PARP in METH-exposed rat cardiomyocytes. In METH-treated chronic lung injury, endoplasmic reticulum stress and endoplasmic reticulum stress-associated kinase pathways were activated to mediate apoptosis in alveolar epithelial cells.
Alternative Names
METH Desoxyephedrine
References
1. Jayanthi S, et al. Neurotoxicity of methamphetamine: Main effects and mechanisms. Exp Neurol. 2021 Oct;344:113795.
2. Coffin PO, et al. Methamphetamine Toxicities and Clinical Management. NEJM Evid. 2023 Dec;2(12):EVIDra2300160.
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.